Complete Filing Data
Horizon Space Acquisition I Corp. reported Stockholders Equity of -$1.74 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Horizon Space Acquisition I Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 |
|---|---|---|
| Net Income * | $2.1M | $2.9M |
| Operating Income Loss | -$1.1M | -$560.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $149.0K | $75.9K | $71.5K | $296.4K | $629.2K | $733.5K | $794.0K | $757.3K | $698.7K | -$650.00 | -$3.2K |
| Operating Income Loss | -$87.4K | -$154.0K | -$153.3K | -$499.3K | -$155.0K | -$147.7K | -$142.2K | -$67.6K | -$117.4K | -$650.00 | -$3.2K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Stockholders Equity | -$1.7M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $561.4K | ||
| Retained Earnings Accumulated Deficit | -$2.5M | -$1.7M | |
| Liabilities Current | $413.7K | $34.8K | |
| Liabilities And Stockholders Equity | $68.2M | $70.9M | |
| Liabilities | $2.8M | $2.4M | |
| Common Stock Value | $231.00 | $231.00 | |
| Assets Held In Trust Noncurrent | $67.9M | $70.2M | |
| Assets Current | $298.9K | $685.5K | |
| Assets | $68.2M | $70.9M | |
| Accounts Payable And Accrued Liabilities Current | $133.7K | $34.8K | |
| Deferred Underwriters Discount Non Current | $2.4M | $2.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$275.5K | -$278.1K | |
| Offering Costs Included In Accrued Expenses | $0.00 | $45.0K | |
| Notes Payable Related Party Classified Current | $70.0K | $70.0K | $0.00 |
| Notes Payable Current | |||
| Interest And Dividend Income On Investments Held In Trust Account | |||
| Deferred Underwriting Commission Charged To Additional Paid In Capital | $0.00 | ||
| Cash And Cash Equivalents At Carrying Value | |||
| Unrealized Gain Loss On Investments |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$5.9M | -$5.4M | -$4.9M | -$4.4M | -$3.9M | -$3.2M | -$2.9M | -$2.5M | -$2.2M | -$2.0M | -$1.9M | $21.1K | -$3.2K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $7.7K | $13.3K | $50.8K | $7.8K | $128.2K | $21.9K | $93.1K | $283.3K | $289.5K | $374.6K | $402.8K | $0.00 | $0.00 | |
| Retained Earnings Accumulated Deficit | -$5.9M | -$5.4M | -$4.9M | -$4.4M | -$3.9M | -$3.2M | -$2.9M | -$2.2M | -$2.0M | -$1.9M | ||||
| Liabilities Current | $3.5M | $3.1M | $2.6M | $2.0M | $1.6M | $879.7K | $616.3K | $124.5K | $45.0K | $8.0K | ||||
| Liabilities And Stockholders Equity | $23.1M | $22.6M | $22.0M | $21.3M | $62.3M | $61.2M | $60.3M | $73.2M | $72.3M | $71.6M | ||||
| Liabilities | $5.9M | $5.5M | $5.0M | $4.4M | $4.0M | $3.3M | $3.0M | $2.5M | $2.5M | $2.4M | ||||
| Common Stock Value | $231.00 | $231.00 | $231.00 | $231.00 | $231.00 | $231.00 | $231.00 | $231.00 | $231.00 | $231.00 | ||||
| Assets Held In Trust Noncurrent | $23.1M | $22.5M | $21.9M | $21.3M | $62.1M | $61.1M | $60.2M | $72.9M | $71.9M | $71.0M | ||||
| Assets Current | $28.9K | $55.8K | $114.6K | $7.8K | $148.4K | $82.3K | $153.9K | $352.6K | $485.3K | $560.9K | ||||
| Assets | $23.1M | $22.6M | $22.0M | $21.3M | $62.3M | $61.2M | $60.3M | $73.2M | $72.3M | $71.6M | ||||
| Accounts Payable And Accrued Liabilities Current | $257.7K | $197.1K | $211.9K | $201.8K | $285.2K | $19.7K | $136.3K | $54.5K | $45.0K | $8.0K | ||||
| Deferred Underwriters Discount Non Current | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $43.0K | -$190.2K | -$158.7K | $0.00 | $0.00 | |||||||||
| Offering Costs Included In Accrued Expenses | $0.00 | $0.00 | ||||||||||||
| Notes Payable Related Party Classified Current | $70.0K | $70.0K | ||||||||||||
| Notes Payable Current | $2.0M | $1.7M | $1.4M | $1.0M | ||||||||||
| Interest And Dividend Income On Investments Held In Trust Account | $0.00 | |||||||||||||
| Deferred Underwriting Commission Charged To Additional Paid In Capital | ||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $402.8K | $561.4K | ||||||||||||
| Unrealized Gain Loss On Investments | $816.1K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$975.5K | -$378.1K | |
| Increase Decrease In Prepaid Expense | $15.6K | $108.4K | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $68.1K | $53.9K | |
| Net Cash Provided By Used In Investing Activities | $49.8M | $5.7M | |
| Proceeds From Sale Of Other Investments | $50.6M | $78.1M | |
| Net Cash Provided By Used In Financing Activities | -$49.1M | -$5.6M | |
| Increase Decrease In Prepaid Expense Noncurrent | $0.00 | $19.7K | |
| Proceeds From Related Party Debt | $0.00 | ||
| Payments To Acquire Leases Held For Investment | $0.00 | $72.1M | |
| Proceeds From Promissory Notes | $210.0K | ||
| Proceeds From Notes Payable | |||
| Share Based Compensation | $0.00 | $93.8K | |
| Payments To Acquire Other Investments | |||
| Proceeds From Issuance Of Private Placement | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$207.0K | -$190.2K | -$158.7K | -$3.9K | $0.00 |
| Increase Decrease In Prepaid Expense | $63.8K | $45.1K | $34.1K | $0.00 | $0.00 |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $10.0K | $2.6K | -$26.8K | $0.00 | -$3.2K |
| Net Cash Provided By Used In Investing Activities | -$360.0K | $8.7M | $0.00 | $0.00 | $0.00 |
| Proceeds From Sale Of Other Investments | $0.00 | $8.9M | $0.00 | $0.00 | $0.00 |
| Net Cash Provided By Used In Financing Activities | $610.0K | -$8.7M | $0.00 | $3.9K | |
| Increase Decrease In Prepaid Expense Noncurrent | $0.00 | -$19.7K | $0.00 | ||
| Proceeds From Related Party Debt | $250.0K | $0.00 | |||
| Payments To Acquire Leases Held For Investment | |||||
| Proceeds From Promissory Notes | $200.0K | $0.00 | |||
| Proceeds From Notes Payable | $360.0K | $200.0K | |||
| Share Based Compensation | |||||
| Payments To Acquire Other Investments | $0.00 | $0.00 | |||
| Proceeds From Issuance Of Private Placement |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | |
| Common Stock Shares Issued | 2.3M | 2.3M | |
| Basic And Diluted Weighted Average Redeemable Ordinary Shares Outstanding | 5.6M | 6.8M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | |
| Ordinary Shares Possible Redemption Value Per Share | $10.72 | $10.18 | |
| Common Stock Shares Outstanding | 2.3M | 2.3M | |
| Common Stock Shares Authorized | 490.0M | 490.0M | |
| Basic And Diluted Weighted Average Non Redeemables Ordinary Shares Outstanding | |||
| Basic And Diluted Weighted Average Non Redeemable Ordinary Shares Outstanding | 2.3M | 2.3M | |
| Founder Shares Issued To Initial Shareholders Amount | |||
| Shares Issued | 200.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Issued | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 10.0K | |
| Basic And Diluted Weighted Average Redeemable Ordinary Shares Outstanding | 1.9M | 1.9M | 1.9M | 5.5M | 5.5M | 6.3M | 6.9M | 6.9M | 6.9M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Ordinary Shares Possible Redemption Value Per Share | $12.43 | $12.11 | $11.79 | $11.48 | $11.25 | $11.07 | $10.90 | $10.56 | $10.42 | $10.30 | ||
| Common Stock Shares Outstanding | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | ||
| Common Stock Shares Authorized | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | ||
| Basic And Diluted Weighted Average Non Redeemables Ordinary Shares Outstanding | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | |||
| Basic And Diluted Weighted Average Non Redeemable Ordinary Shares Outstanding | 2.3M | 2.3M | 2.3M | 1.5M | 1.5M | |||||||
| Founder Shares Issued To Initial Shareholders Amount | 25.0K | 1.00 | ||||||||||
| Shares Issued | 200.0K | 200.0K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Operating Costs And Expenses | $1.1M | $560.2K | |
| Basic And Diluted Net Loss Per Non Redeemable Ordinary Share | -$0.23 | -$0.08 | |
| Basic And Diluted Net Income Per Redeemable Ordinary Shares | 0.47 | 0.46 | |
| Investment Income Interest And Dividend | $3.2M | $3.5M | |
| Subsequent Accretion Of Redemption Net Value | -$4.0M | -$3.7M | |
| Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares | 67.9M | 70.2M | |
| Prepaid Expense Current | $15.6K | $124.1K | |
| Ordinary Shares Possible Redemption | 6.3M | 6.9M | |
| Additional Paid In Capital | $0.00 | $0.00 | |
| Subsequent Accretion Of Carrying Value Of Public Shares To Redemption Value | |||
| Subsequent Accretion Of Carrying Value For Public Shares To Redemption Value | -4.0M | -3.7M | |
| Promissory Notes Current | $1.0M | $210.0K | $0.00 |
| Extension Loan Related Party Amount | |||
| Prepaid Expense Noncurrent | $0.00 | $19.7K | |
| Ordinary Shares Redemption | 50.6M | 5.9M | |
| Monthly Extension Fee Deposited Into Trust Account | $800.0K | $280.0K | |
| Initial Accretion Of Carrying Value To Redemption Value | |||
| Working Capital Loan From Related Party Amount | |||
| Payment For Ordinary Shares Redemption | |||
| Payment For Monthly Extension Fee Deposited Into Trust Account | |||
| Offering Cost | -$45.0K | ||
| Subsequent Accretion Of Carrying Value Or Public Shares To Redemption Value | 0.00 | ||
| Capital Loan From Related Party Adjusted Balance | |||
| Offering Costs Paid By Sponsor In Exchange For Issuance Of Ordinary Shares | 0.00 | ||
| Issuance Of Representative Shares | 0.00 | ||
| Founder Shares Surrendered Amount |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Costs And Expenses | $87.4K | $154.0K | $153.3K | $499.3K | $155.0K | $147.7K | $142.2K | $67.6K | $117.4K | $650.00 | $3.2K | ||
| Basic And Diluted Net Loss Per Non Redeemable Ordinary Share | -$0.11 | -$0.12 | -$0.12 | -$0.09 | -$0.04 | -$0.04 | -$0.02 | -$0.01 | -$0.01 | $0.00 | $0.00 | ||
| Basic And Diluted Net Income Per Redeemable Ordinary Shares | 0.21 | 0.19 | 0.19 | 0.09 | 0.13 | 0.13 | 0.12 | 0.11 | 0.11 | 0.00 | 0.00 | ||
| Investment Income Interest And Dividend | $236.5K | $229.9K | $224.8K | $795.7K | $784.2K | $881.1K | $936.2K | $824.9K | $816.1K | $0.00 | $0.00 | ||
| Subsequent Accretion Of Redemption Net Value | -$596.5K | -$589.9K | -$584.8K | -$975.7K | -$964.2K | -$1.1M | -$1.0M | -$824.9K | -$816.1K | ||||
| Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares | 23.1M | 22.5M | 21.9M | 21.3M | 62.1M | 61.1M | 60.2M | 72.9M | 71.9M | 71.0M | |||
| Prepaid Expense Current | $21.3K | $42.5K | $63.8K | $0.00 | $20.3K | $60.4K | $60.8K | $63.1K | $110.7K | $158.2K | |||
| Ordinary Shares Possible Redemption | 1.9M | 1.9M | 1.9M | 1.9M | 5.5M | 5.5M | 5.5M | 6.9M | 6.9M | 6.9M | |||
| Additional Paid In Capital | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Subsequent Accretion Of Carrying Value Of Public Shares To Redemption Value | -584.8K | -1.1M | |||||||||||
| Subsequent Accretion Of Carrying Value For Public Shares To Redemption Value | -816.1K | 0.00 | 0.00 | ||||||||||
| Promissory Notes Current | $770.0K | $590.0K | $410.0K | ||||||||||
| Extension Loan Related Party Amount | $190.0K | $70.0K | $70.0K | $70.0K | $70.0K | $70.0K | $70.0K | ||||||
| Prepaid Expense Noncurrent | $0.00 | $0.00 | $0.00 | ||||||||||
| Ordinary Shares Redemption | 8.9M | 0.00 | |||||||||||
| Monthly Extension Fee Deposited Into Trust Account | $200.0K | $0.00 | |||||||||||
| Initial Accretion Of Carrying Value To Redemption Value | -$1.0M | -$824.9K | -$816.1K | ||||||||||
| Working Capital Loan From Related Party Amount | $1.1M | $1.1M | $950.0K | $700.0K | |||||||||
| Payment For Ordinary Shares Redemption | 0.00 | 8.9M | |||||||||||
| Payment For Monthly Extension Fee Deposited Into Trust Account | $360.0K | $200.0K | |||||||||||
| Offering Cost | -$45.0K | ||||||||||||
| Subsequent Accretion Of Carrying Value Or Public Shares To Redemption Value | -1.1M | -816.1K | |||||||||||
| Capital Loan From Related Party Adjusted Balance | $500.0K | $200.0K | $0.00 | ||||||||||
| Offering Costs Paid By Sponsor In Exchange For Issuance Of Ordinary Shares | |||||||||||||
| Issuance Of Representative Shares | |||||||||||||
| Founder Shares Surrendered Amount | -1.00 |
Most recent annual filing with the SEC: March 28, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.